167 related articles for article (PubMed ID: 31744296)
1. Biomimetic and Self-Assembled Nanoclusters Targeting β-Catenin for Potent Anticancer Therapy and Enhanced Immunotherapy.
Liu J; Yan J; Yan S; Wang Y; Zhang R; Hou P; He W; Ji M
Nano Lett; 2019 Dec; 19(12):8708-8715. PubMed ID: 31744296
[TBL] [Abstract][Full Text] [Related]
2. Targeting β-catenin and PD-L1 simultaneously by a racemic supramolecular peptide for the potent immunotherapy of hepatocellular carcinoma.
Zhou Z; Li X; Yang G; Wang J; Li B; Huang Y; Yan J; Tao K
Theranostics; 2023; 13(10):3371-3386. PubMed ID: 37351175
[No Abstract] [Full Text] [Related]
3. Wnt/beta-catenin pathway: modulating anticancer immune response.
Pai SG; Carneiro BA; Mota JM; Costa R; Leite CA; Barroso-Sousa R; Kaplan JB; Chae YK; Giles FJ
J Hematol Oncol; 2017 May; 10(1):101. PubMed ID: 28476164
[TBL] [Abstract][Full Text] [Related]
4. Sequential modulation of the Wnt/β-catenin signaling pathway enhances tumor-intrinsic MHC I expression and tumor clearance.
Dholakia J; Scalise CB; Katre AA; Goldsberry WN; Meza-Perez S; Randall TD; Norian LA; Novak L; Arend RC
Gynecol Oncol; 2022 Jan; 164(1):170-180. PubMed ID: 34844776
[TBL] [Abstract][Full Text] [Related]
5. RNAi-Mediated β-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade.
Ganesh S; Shui X; Craig KP; Park J; Wang W; Brown BD; Abrams MT
Mol Ther; 2018 Nov; 26(11):2567-2579. PubMed ID: 30274786
[TBL] [Abstract][Full Text] [Related]
6. Carnosic acid nanocluster-based framework combined with PD-1 inhibitors impeded tumorigenesis and enhanced immunotherapy in hepatocellular carcinoma.
Wu W; Li Y; Wu X; Liang J; You W; He X; Feng Q; Li T; Jia X
Funct Integr Genomics; 2024 Jan; 24(1):5. PubMed ID: 38182693
[TBL] [Abstract][Full Text] [Related]
7. An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid.
de la Roche M; Rutherford TJ; Gupta D; Veprintsev DB; Saxty B; Freund SM; Bienz M
Nat Commun; 2012 Feb; 3():680. PubMed ID: 22353711
[TBL] [Abstract][Full Text] [Related]
8. Self-assembled N-cadherin mimetic peptide hydrogels promote the chondrogenesis of mesenchymal stem cells through inhibition of canonical Wnt/β-catenin signaling.
Li R; Xu J; Wong DSH; Li J; Zhao P; Bian L
Biomaterials; 2017 Nov; 145():33-43. PubMed ID: 28843065
[TBL] [Abstract][Full Text] [Related]
9. Taxifolin curbs NF-κB-mediated Wnt/β-catenin signaling via up-regulating Nrf2 pathway in experimental colon carcinogenesis.
Manigandan K; Manimaran D; Jayaraj RL; Elangovan N; Dhivya V; Kaphle A
Biochimie; 2015 Dec; 119():103-12. PubMed ID: 26482805
[TBL] [Abstract][Full Text] [Related]
10. Modulating β-catenin/BCL9 interaction with cell-membrane-camouflaged carnosic acid to inhibit Wnt pathway and enhance tumor immune response.
Gao R; Zheng X; Jiang A; He W; Liu T
Front Immunol; 2023; 14():1274223. PubMed ID: 37881428
[TBL] [Abstract][Full Text] [Related]
11. WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment.
Li X; Xiang Y; Li F; Yin C; Li B; Ke X
Front Immunol; 2019; 10():2293. PubMed ID: 31616443
[TBL] [Abstract][Full Text] [Related]
12. Self-Assembly of Therapeutic Peptide into Stimuli-Responsive Clustered Nanohybrids for Cancer-Targeted Therapy.
He W; Wang S; Yan J; Qu Y; Jin L; Sui F; Li Y; You W; Yang G; Yang Q; Ji M; Shao Y; Ma PX; Lu W; Hou P
Adv Funct Mater; 2019 Mar; 29(10):. PubMed ID: 32982625
[TBL] [Abstract][Full Text] [Related]
13. Targeting Wnt/β-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF.
Wang H; Zhang H; Chen Y; Wang H; Tian Y; Yi X; Shi Q; Zhao T; Zhang B; Gao T; Guo S; Li C; Guo W
Cells; 2022 Nov; 11(22):. PubMed ID: 36429010
[TBL] [Abstract][Full Text] [Related]
14. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
[TBL] [Abstract][Full Text] [Related]
15. Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity.
Suryawanshi A; Hussein MS; Prasad PD; Manicassamy S
Front Immunol; 2020; 11():122. PubMed ID: 32132993
[TBL] [Abstract][Full Text] [Related]
16. Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling.
Hwang SY; Deng X; Byun S; Lee C; Lee SJ; Suh H; Zhang J; Kang Q; Zhang T; Westover KD; Mandinova A; Lee SW
Cell Rep; 2016 Jun; 16(1):28-36. PubMed ID: 27320923
[TBL] [Abstract][Full Text] [Related]
17. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
18. A
Wang J; Zheng X; Fu X; Jiang A; Yao Y; He W
Theranostics; 2023; 13(11):3844-3855. PubMed ID: 37441586
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
Cheng X; Xu X; Chen D; Zhao F; Wang W
Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
[TBL] [Abstract][Full Text] [Related]
20. The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase.
Okada-Iwasaki R; Takahashi Y; Watanabe Y; Ishida H; Saito J; Nakai R; Asai A
Mol Cancer Ther; 2016 Jul; 15(7):1525-34. PubMed ID: 27196752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
